Equity research valuations and risk assessments for Almarai, BAE Systems, Dallah Healthcare, and Dar Al Arkan

Equity research valuations and risk assessments for Almarai, BAE Systems, Dallah Healthcare, and Dar Al Arkan The document contains standard financial analysis and valuation metrics without any mention of wrongdoing, influential political actors, or controversial financial flows. It offers no actionable investigative leads. Key insights: Valuation multiples and price objectives for four companies; Identified macro and company-specific risk factors; DCF assumptions such as WACC and growth rates